Rabbit C1QBP (D7H12) Monoclonal Antibody

Rabbit C1QBP (D7H12) Monoclonal Antibody

Cat. No.: DAB-0011859

Size: 20 µL Size: 100 µL Size: Customer Size
Product Information
Clonality Monoclonal
Isotype IgG
Host Species Rabbit
Reactivity Human, Mouse, Rat, Monkey
Applications WB, IHC, IF, Flow Cyt
Product Description Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues near the carboxy terminus of human C1QBP protein.
Format Liquid
Purity Affinity purity
Target Information
Target Name C1QBP
UniProt No. Q07021
Gene ID 708
Gene Description C1QBP, also referred to as p32, p33, gC1q receptor, and hyaluronic acid binding protein 1, was originally identified via its binding interactions with Splicing Factor. Multiple, diverse binding partners of C1QBP were subsequently identified, including the globular heads of complement component C1q, hyaluronic acid, selected protein kinases, the tumor suppressor ARF, and multiple antigens of bacterial and viral origin. Research studies have shown that C1QBP is overexpressed in a number of cancer cell types, and has been implicated in the Warburg effect, whereby cancer cells shift their metabolism from oxidative phosphorylation to glycolysis. C1QBP has also been shown to inhibit the Mitochondrial Permeability Transition pore, possibly serving a protective function against damage from oxidative stress.
Shipping & Storage
Shipping Shipped at 4 °C.
Storage Instructions Store at –20 °C. Do not aliquot the antibody.
Storage Buffer Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA, 50% glycerol and less than 0.02% sodium azide.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Related Products
logo

Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top